User contributions
Jump to navigation
Jump to search
- 11:52, 20 May 2020 diff hist -147 Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5) (Q8462) Page on [sliswiki] deleted: Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5)
- 19:05, 14 May 2020 diff hist -165 Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) Page on [sliswiki] deleted: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
- 18:34, 14 May 2020 diff hist -193 Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) Page on [sliswiki] deleted: Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265)
- 18:34, 14 May 2020 diff hist -178 Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) Page on [sliswiki] deleted: Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265)
- 18:34, 14 May 2020 diff hist -165 Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) Page on [sliswiki] deleted: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
- 18:33, 14 May 2020 diff hist -162 Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413) Page on [sliswiki] deleted: Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265)
- 18:31, 14 May 2020 diff hist -154 Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406) Page on [sliswiki] deleted: Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265)
- 18:30, 14 May 2020 diff hist -160 Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) Page on [sliswiki] deleted: Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)
- 18:29, 14 May 2020 diff hist -150 Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8408) Page on [sliswiki] deleted: Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
- 18:29, 14 May 2020 diff hist -201 Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) Page on [sliswiki] deleted: Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265)
- 17:45, 14 May 2020 diff hist -160 Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409) Page on [sliswiki] deleted: Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265)
- 16:57, 14 May 2020 diff hist -174 Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396) Page on [sliswiki] deleted: Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265)
- 16:48, 14 May 2020 diff hist -162 Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) (Q8417) Page on [sliswiki] deleted: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265)
- 16:47, 14 May 2020 diff hist -148 Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) (Q8419) Page on [sliswiki] deleted: Disclosure statement (from DOI: 10.1080/22221751.2020.1735265)
- 16:29, 14 May 2020 diff hist -169 Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415) Page on [sliswiki] deleted: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265)
- 16:22, 14 May 2020 diff hist -224 Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398) Page on [sliswiki] deleted: Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265)
